Skip to main content
SpringerLink
Log in

Liposome-Based Nanovaccines

  • Chapter
  • First Online:
Nanovaccines

Abstract

Liposomes are nanosized lipid particles that have become attractive vaccine delivery vehicles given their properties that include versatility for functionalization, controlled charge, high encapsulation capacity, high surface, and efficient cellular uptake. This chapter contains a description of the liposomes preparation techniques and their application to develop mucosal nanovaccines. The analysis of the current literature reveals that there are many attractive vaccine candidates based on this technology, although the majority have been evaluated in parenteral schemes. The mucosal formulations tested thus far are against parasitic, bacterial, and viral diseases. A cancer vaccine was also developed. The formulations have been assessed in test animals and administered intranasally, orally, sublingually, and by the airways. Immunogenicity assessment in preclinical studies supports the use of liposomes to enhance cellular and humoral responses. Therefore, liposomes are effective nanoparticles and the outstanding findings from the preclinical evaluation of many mucosal vaccine candidates indicate that there is a good prospect for the initiation of clinical trials in the coming years. The challenges for this field comprise expanding the assessment of mucosal formulations, achieving high stability in the formulation, and scale-up production.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abhyankar MM, Orr MT, Lin S, Suraju MO, Simpson A, Blust M, Pham T, Guderian JA, Tomai MA, Elvecrog J, Pedersen K, Petri WA Jr, Fox CB (2018) Adjuvant composition and delivery route shape immune response quality and protective efficacy of a recombinant vaccine for Entamoeba histolytica. NPJ Vaccines 3:22

    Article  CAS  Google Scholar 

  • Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehpour Y, Samiei M, Kouhi M, Nejati-Koshki K (2013) Liposome: classification, preparation, and applications. Nanoscale Res Lett 8(1):102

    Article  CAS  Google Scholar 

  • Alipour Talesh G, Ebrahimi Z, Badiee A, Mansourian M, Attar H, Arabi L, Jalali SA, Jaafari MR (2016) Poly (I:C)-DOTAP cationic nanoliposome containing multi-epitope HER2-derived peptide promotes vaccine-elicited anti-tumor immunity in a murine model. Immunol Lett 176:57–64

    Article  CAS  Google Scholar 

  • Allen TM, Cullis PR (2013) Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev 65(1):36–48

    Article  CAS  Google Scholar 

  • Arab A, Behravan J, Razazan A, Gholizadeh Z, Nikpoor AR, Barati N, Mosaffa F, Badiee A, Jaafari MR (2018) A nano-liposome vaccine carrying E75, a HER-2/neu-derived peptide, exhibits significant antitumour activity in mice. J Drug Target 26(4):365–372

    Article  CAS  Google Scholar 

  • Bale S, Goebrecht G, Stano A, Wilson R, Ota T, Tran K, Ingale J, Zwick MB, Wyatt RT (2017) Covalent linkage of HIV-1 trimers to synthetic liposomes elicits improved B cell and antibody responses. J Virol 91(16):e00443

    Article  CAS  Google Scholar 

  • Barati N, Nikpoor AR, Razazan A, Mosaffa F, Badiee A, Arab A, Gholizadeh Z, Behravan J, Jaafari MR (2017) Nanoliposomes carrying HER2/neu-derived peptide AE36 with CpG-ODN exhibit therapeutic and prophylactic activities in a mice TUBO model of breast cancer. Immunol Lett 190:108–117

    Article  CAS  Google Scholar 

  • Broecker F, Götze S, Hudon J, Rathwell DCK, Pereira CL, Stallforth P, Anish C, Seeberger PH (2018) Synthesis, liposomal formulation, and immunological evaluation of a minimalistic carbohydrate-α-GalCer vaccine candidate. J Med Chem 61(11):4918–4927

    Article  CAS  Google Scholar 

  • Bulbake U, Doppalapudi S, Kommineni N, Khan W (2017) Liposomal formulations in clinical use: an updated review. Pharmaceutics 9(2):E12

    Article  CAS  Google Scholar 

  • Carneiro C, Correia A, Lima T, Vilanova M, Pais C, Gomes AC, Real Oliveira MECD, Sampaio P (2016) Protective effect of antigen delivery using monoolein-based liposomes in experimental hematogenously disseminated candidiasis. Acta Biomater 39:133–145

    Article  CAS  Google Scholar 

  • Clark MA, Blair H, Liang L, Brey RN, Brayden D, Hirst BH (2001) Targeting polymerised liposome vaccine carriers to intestinal M cells. Vaccine 20(1-2):208–217

    Article  CAS  Google Scholar 

  • de Araújo Lopes SC, dos Santos Giuberti C, Rocha TGR, dos Santos Ferreira D, Leite EA, Oliveira MC (2013) Liposomes as carriers of anticancer drugs. In: Cancer treatment-conventional and innovative approaches. IntechOpen, London

    Google Scholar 

  • Del Giudice G, Rappuoli R, Didierlaurent AM (2018) Correlates of adjuvanticity: a review on adjuvants in licensed vaccines. Semin Immunol 39:14–21

    Article  CAS  Google Scholar 

  • Fan Y, Sahdev P, Ochyl LJ, Akerberg J, Moon JJ (2015) Cationic liposome-hyaluronic acid hybrid nanoparticles for intranasal vaccination with subunit antigens. J Control Release 208:121–129

    Article  CAS  Google Scholar 

  • Fotoran WL, Santangelo RM, Medeiros MM, Colhone M, Ciancaglini P, Barboza R, Marinho CR, Stábeli RG, Wunderlich G (2015) Liposomes loaded with P. falciparum merozoite-derived proteins are highly immunogenic and produce invasion-inhibiting and anti-toxin antibodies. J Control Release 217:121–127

    Article  CAS  Google Scholar 

  • Gammon JM, Jewell CM (2019) Engineering immune tolerance with biomaterials. Adv Healthc Mater 8(4):e1801419

    Article  CAS  Google Scholar 

  • Gargett T, Abbas MN, Rolan P, Price JD, Gosling KM, Ferrante A, Ruszkiewicz A, Atmosukarto IIC, Altin J, Parish CR, Brown MP (2018) Phase I trial of Lipovaxin-MM, a novel dendritic cell-targeted liposomal vaccine for malignant melanoma. Cancer Immunol Immunother 67(9):1461–1472

    Article  CAS  Google Scholar 

  • Ghaffar KA, Marasini N, Giddam AK, Batzloff MR, Good MF, Skwarczynski M, Toth I (2016) Liposome-based intranasal delivery of lipopeptide vaccine candidates against group A streptococcus. Acta Biomater 41:161–168

    Article  CAS  Google Scholar 

  • Gharib R, Greige-Gerges H, Jraij A, Auezova L, Charcosset C (2016) Preparation of drug-in-cyclodextrin-in-liposomes at a large scale using a membrane contactor: application to trans-anethole. Carbohydr Polym 154:276–286

    Article  CAS  Google Scholar 

  • Glueck R (2001) Review of intranasal influenza vaccine. Adv Drug Deliv Rev 51(1-3):203–211

    Article  CAS  Google Scholar 

  • Hanson MC, Abraham W, Crespo MP, Chen SH, Liu H, Szeto GL, Kim M, Reinherz EL, Irvine DJ (2015) Liposomal vaccines incorporating molecular adjuvants and intrastructural T-cell help promote the immunogenicity of HIV membrane-proximal external region peptides. Vaccine 33(7):861–868

    Article  CAS  Google Scholar 

  • Harde H, Agrawal AK, Jain S (2015a) Trilateral ‘3P’ mechanics of stabilized layersomes technology for efficient oral immunization. J Biomed Nanotechnol 11(3):363–381

    Article  CAS  Google Scholar 

  • Harde H, Agrawal AK, Jain S (2015b) Tetanus toxoid-loaded layer-by-layer nanoassemblies for efficient systemic, mucosal, and cellular immunostimulatory response following oral administration. Drug Deliv Transl Res 5(5):498–510

    Article  CAS  Google Scholar 

  • Harde H, Siddhapura K, Agrawal AK, Jain S (2015c) Development of dual toxoid-loaded layersomes for complete immunostimulatory response following peroral administration. Nanomedicine 10(7):1077–1091

    Article  CAS  Google Scholar 

  • Horiuchi Y, Takagi A, Uchida T, Akatsuka T (2015) Targeting cryptic epitope with modified antigen coupled to the surface of liposomes induces strong antitumor CD8 T-cell immune responses in vivo. Oncol Rep 34(6):2827–2836

    Article  CAS  Google Scholar 

  • Immordino ML, Dosio F, Cattel L (2006) Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomedicine 1(3):297

    Article  CAS  Google Scholar 

  • Islam MA, Firdous J, Badruddoza AZM, Reesor E, Azad M, Hasan A, Lim M, Cao W, Guillemette S, Cho CS (2019) M cell targeting engineered biomaterials for effective vaccination. Biomaterials 192:75–94

    Article  CAS  Google Scholar 

  • Iwama T, Uchida T, Sawada Y, Tsuchiya N, Sugai S, Fujinami N, Shimomura M, Yoshikawa T, Zhang R, Uemura Y, Nakatsura T (2016) Vaccination with liposome-coupled glypican-3-derived epitope peptide stimulates cytotoxic T lymphocytes and inhibits GPC3-expressing tumor growth in mice. Biochem Biophys Res Commun 469(1):138–143

    Article  CAS  Google Scholar 

  • Kakhi Z, Frisch B, Bourel-Bonnet L, Hemmerlé J, Pons F, Heurtault B (2015) Airway administration of a highly versatile peptide-based liposomal construct for local and distant antitumoral vaccination. Int J Pharm 496(2):1047–1056

    Article  CAS  Google Scholar 

  • Kakhi Z, Frisch B, Heurtault B, Pons F (2016) Liposomal constructs for antitumoral vaccination by the nasal route. Biochimie 130:14–22

    Article  CAS  Google Scholar 

  • Kaneko K, McDowell A, Ishii Y, Hook S (2017) Characterization and evaluation of stabilized particulate formulations as therapeutic oral vaccines for allergy. J Liposome Res 5:1–9

    Google Scholar 

  • Knotigová PT, Zyka D, Mašek J, Kovalová A, Křupka M, Bartheldyová E, Kulich P, Koudelka Š, Lukáč R, Kauerová Z, Vacek A, Horynová MS, Kozubík A, Miller AD, Fekete L, Kratochvílová I, Ježek J, Ledvina M, Raška M, Turánek J (2015) Molecular adjuvants based on nonpyrogenic lipophilic derivatives of norAbuMDP/GMDP formulated in nanoliposomes: stimulation of innate and adaptive immunity. Pharm Res 32(4):1186–1199

    Article  CAS  Google Scholar 

  • Larrouy-Maumus G, Layre E, Clark S, Prandi J, Rayner E, Lepore M, de Libero G, Williams A, Puzo G, Gilleron M (2017) Protective efficacy of a lipid antigen vaccine in a guinea pig model of tuberculosis. Vaccine 35(10):1395–1402

    Article  CAS  Google Scholar 

  • Lycke N (2012) Recent progress in mucosal vaccine development: potential and limitations. Nat Rev Immunol 12(8):592–605

    Article  CAS  Google Scholar 

  • Lycke NY, Bemark M (2017) The regulation of gut mucosal IgA B-cell responses: recent developments. Mucosal Immunol 10(6):1361–1374

    Article  CAS  Google Scholar 

  • Lyon PC, Gray MD, Mannaris C, Folkes LK, Stratford M, Campo L, Chung DYF, Scott S, Anderson M, Goldin R, Carlisle R, Wu F, Middleton MR, Gleeson FV, Coussios CC (2018) Safety and feasibility of ultrasound-triggered targeted drug delivery of doxorubicin from thermosensitive liposomes in liver tumours (TARDOX): a single-centre, open-label, phase 1 trial. Lancet Oncol 19(8):1027–1039

    Article  CAS  Google Scholar 

  • Marasini N, Giddam AK, Ghaffar KA, Batzloff MR, Good MF, Skwarczynski M, Toth I (2016) Multilayer engineered nanoliposomes as a novel tool for oral delivery of lipopeptide-based vaccines against group A Streptococcus. Nanomedicine 11(10):1223–1236

    Article  CAS  Google Scholar 

  • Miquel-Clopés A, Bentley EG, Stewart JP, Carding SR (2019) Mucosal vaccines and technology. Clin Exp Immunol 196(2):205–214

    Google Scholar 

  • Naseri H, Eskandari F, Jaafari MR, Khamesipour A, Abbasi A, Badiee A (2017) PEGylation of cationic liposomes encapsulating soluble Leishmania antigens reduces the adjuvant efficacy of liposomes in murine model. Parasite Immunol 39(11):12492

    Article  CAS  Google Scholar 

  • Neumann S, Young K, Compton B, Anderson R, Painter G, Hook S (2015) Synthetic TRP2 long-peptide and α-galactosylceramide formulated into cationic liposomes elicit CD8+ T-cell responses and prevent tumour progression. Vaccine 33(43):5838–5844

    Article  CAS  Google Scholar 

  • Nisini R, Poerio N, Mariotti S, De Santis F, Fraziano M (2018) The multirole of liposomes in therapy and prevention of infectious diseases. Front Immunol 9:155

    Article  CAS  Google Scholar 

  • Oberoi HS, Yorgensen YM, Morasse A, Evans JT, Burkhart DJ (2016) PEG modified liposomes containing CRX-601 adjuvant in combination with methylglycol chitosan enhance the murine sublingual immune response to influenza vaccination. J Control Release 223:64–74

    Article  CAS  Google Scholar 

  • Pati R, Shevtsov M, Sonawane A (2018) Nanoparticle vaccines against infectious diseases. Front Immunol 9:2224

    Article  CAS  Google Scholar 

  • Razazan A, Behravan J, Arab A, Barati N, Arabi L, Gholizadeh Z, Hatamipour M, Reza Nikpoor A, Momtazi-Borojeni AA, Mosaffa F, Ghahremani MH, Jaafari MR (2017) Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model. PLoS One 12(10):e0185099

    Article  CAS  Google Scholar 

  • Renukuntla J, Vadlapudi AD, Patel A, Boddu SH, Mitra AK (2013) Approaches for enhancing oral bioavailability of peptides and proteins. Int J Pharm 447(1-2):75–93

    Article  CAS  Google Scholar 

  • Rico AB, Phillips AT, Schountz T, Jarvis DL, Tjalkens RB, Powers AM, Olson KE (2016) Venezuelan and western equine encephalitis virus E1 liposome antigen nucleic acid complexes protect mice from lethal challenge with multiple alphaviruses. Virology 499:30–39

    Article  CAS  Google Scholar 

  • Schubert R (2003) Liposome preparation by detergent removal. Methods Enzymol 367:46–70

    Article  CAS  Google Scholar 

  • Sebaaly C, Charcosset C, Stainmesse S, Fessi H, Greige-Gerges H (2016) Clove essential oil-in-cyclodextrin-in-liposomes in the aqueous and lyophilized states: from laboratory to large scale using a membrane contactor. Carbohydr Polym 138:75–85

    Article  CAS  Google Scholar 

  • Shen KY, Liu HY, Li HJ, Wu CC, Liou GG, Chang YC, Leng CH, Liu SJ (2016) A novel liposomal recombinant lipoimmunogen enhances anti-tumor immunity. J Control Release 233:57–63

    Article  CAS  Google Scholar 

  • Sriwongsitanont S, Ueno M (2010) Effect of freeze-thawing process on the size and lamellarity of peg-lipid liposomes. Open Coll Sci J 4:1–6

    Google Scholar 

  • Tregoning JS, Russell RF, Kinnear E (2018) Adjuvanted influenza vaccines. Hum Vaccin Immunother 14(3):550–564

    Article  Google Scholar 

  • Umlauf BJ, Chung CY, Brown KC (2015) Modular three-component delivery system facilitates HLA class I antigen presentation and CD8(+) T-cell activation against tumors. Mol Ther 23(6):1092–1102

    Article  CAS  Google Scholar 

  • Verma AK, Sharma S, Gupta P, Singodia D, Kansal S, Sharma V, Mishra PR (2016) Vitamin B12 grafted layer-by-layer liposomes bearing HBsAg facilitate oral immunization: effect of modulated biomechanical properties. Mol Pharm 13(7):2531–2542

    Article  CAS  Google Scholar 

  • Wang N, Chen M, Wang T (2019) Liposomes used as a vaccine adjuvant-delivery system: from basics to clinical immunization. J Control Release 303:130–150

    Article  CAS  Google Scholar 

  • Yusuf H, Ali AA, Orr N, Tunney MM, McCarthy HO, Kett VL (2017) Novel freeze-dried DDA and TPGS liposomes are suitable for nasal delivery of vaccine. Int J Pharm 533(1):179–186

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Facultad de Ciencias Químicas, Centro de Investigación en Ciencias de la Salud y Biomedicina, Universidad Autónoma de San Luis Potosí, San Luis Potosí, Mexico

    Sergio Rosales-Mendoza

  2. Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí , San Luis Potosí, Mexico

    Omar González-Ortega

Authors
  1. Sergio Rosales-Mendoza
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Omar González-Ortega
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Rosales-Mendoza, S., González-Ortega, O. (2019). Liposome-Based Nanovaccines. In: Nanovaccines. Springer, Cham. https://doi.org/10.1007/978-3-030-31668-6_9

Download citation

Publish with us

Policies and ethics

Search

Navigation